DocWire News spoke with Raj Chakraborty, MD, assistant professor of medicine at Columbia University Irving Medical Center, Division of Hematology/Oncology, on how new research on treatments for multiple myeloma may impact the treatment landscape, and challenges and opportunities from the paradigm shift from triplet to quadruplet therapy.

This is the second of a four-part conversation with Dr. Chakraborty. Watch part one, where Dr. Chakraborty discusses recent clinical trials for newly-diagnosed multiple myeloma.